Agios Pharma (AGIO) Misses Q3 EPS by 3c

Agios Pharma (NASDAQ: AGIO) reported Q3 EPS of ($1.63), $0.03 worse than the analyst estimate of ($1.60). Revenue for the quarter came in at $15.2 million versus the consensus estimate of $20.08 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• Are we witnessing a fundamental or speculative rally in the S&P 500?
• Broadcom (AVGO) Tops Q2 EPS by 5c, Offers Guidance
• IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance